سعر جريداموم 0.1% كريم 30 جم 2022

Mometasone furoate 0.1% topical cream (30 g), a medium-potency topical corticosteroid; Egyptian product by Global Napi Pharmaceuticals.

• Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.Population: Patients 2 years of age or olderDailyMed (U.S. National Library of Medicine)

• Clinical trials: adverse reactions in 1.6% (burning, pruritus, skin atrophy); rosacea reported; in children 2-12 years about 7% (stinging, pruritus, furunculosis). Post-marketing (topical corticosteroids): irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, secondary infection, striae, miliaria; blurred vision, cataracts, glaucoma, raised intraocular pressure, central serous chorioretinopathy.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• History of hypersensitivity to mometasone furoate or to any component of the preparation.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Systemic absorption can cause reversible HPA axis suppression with potential glucocorticosteroid insufficiency, Cushing's syndrome, hyperglycaemia and glucosuria; risk factors include large treatment areas, prolonged use, occlusion, altered skin barrier, liver failure and young age.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Paediatric patients may be more susceptible to systemic toxicity (larger skin surface to body mass ratio), including HPA axis suppression, Cushing's syndrome, linear growth retardation, delayed weight gain and intracranial hypertension.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Topical corticosteroids may increase the risk of posterior subcapsular cataracts and glaucoma; avoid contact with eyes and refer patients with visual symptoms to an ophthalmologist.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• No adequate and well-controlled studies in pregnant women; use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Mometasone furoate increased fetal malformations in rats, rabbits and mice.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• It is not known whether topical corticosteroids are absorbed sufficiently to appear in breast milk; exercise caution when used by a nursing woman.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Mometasone furoate: Synthetic corticosteroid with anti-inflammatory, antipruritic and vasoconstrictive activity (US label).